Mirum Pharmaceuticals, Inc.(MIRM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MIRM Mirum Pharmaceuticals, Inc.

已收盘 07-09 16:00:00 EDT

53.46

+3.19

+6.35%

盘后53.46

+0.000.00%

19:55 EDT

最高53.86	最低50.69	成交量70.32万
今开50.69	昨收50.27	日振幅6.31%
总市值26.48亿	流通市值21.14亿	总股本4,953万
成交额3,731万	换手率1.78%	流通股本3,955万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MIRM","market":"US","secType":"STK","nameCN":"Mirum Pharmaceuticals, Inc.","latestPrice":53.46,"timestamp":1752091200000,"preClose":50.27,"halted":0,"volume":703172,"hourTrading":{"tag":"盘后","latestPrice":53.46,"preClose":53.46,"latestTime":"19:55 EDT","volume":44441,"amount":2375940.2955,"timestamp":1752105345050},"delay":0,"floatShares":39545262,"shares":49534709,"eps":-1.610814,"marketStatus":"已收盘","change":3.19,"latestTime":"07-09 16:00:00 EDT","open":50.69,"high":53.86,"low":50.69,"amount":37314808.027144,"amplitude":0.063059,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.610814,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752134400000},"marketStatusCode":5,"adr":0,"listingDate":1563422400000,"exchange":"NASDAQ","adjPreClose":50.27,"preHourTrading":{"tag":"盘前","latestPrice":50.78,"preClose":50.27,"latestTime":"09:29 EDT","volume":314,"amount":15941.920358,"timestamp":1752067799999},"postHourTrading":{"tag":"盘后","latestPrice":53.46,"preClose":53.46,"latestTime":"19:55 EDT","volume":44441,"amount":2375940.2955,"timestamp":1752105345050},"volumeRatio":1.52694,"impliedVol":0.4467,"impliedVolPercentile":0.216},"requestUrl":"/m/hq/s/MIRM","defaultTab":"news","newsList":[{"id":"2550652155","title":"Mirum Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.07%报52.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550652155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550652155?lang=zh_cn&edition=full","pubTime":"2025-07-10 01:04","pubTimestamp":1752080656,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日01时04分，Mirum Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.07%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司， 专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710010417953c6199&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710010417953c6199&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2548884783","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548884783","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548884783?lang=zh_cn&edition=full","pubTime":"2025-07-02 03:14","pubTimestamp":1751397242,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日03时14分，Mirum Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.07%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司， 专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020314029532e96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507020314029532e96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2542634944","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542634944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542634944?lang=zh_cn&edition=full","pubTime":"2025-06-11 00:41","pubTimestamp":1749573711,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日00时41分，Mirum Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.04%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Carisma Therapeutics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nucana Plc涨幅较大，Nucana Plc、Windtree Therapeutics, Inc.、Evogene Ltd.较为活跃，换手率分别为29527.17%、2781.23%、1330.17%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Carisma Therapeutics, Inc.、Klotho Neurosciences, Inc.，振幅分别为261.54%、191.40%、114.83%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司， 专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611004151a4a238ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611004151a4a238ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2536317070","title":"Mirum Pharmaceuticals, Inc.2025财年第一财季实现净利润-14.68百万美元，同比增加41.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536317070","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536317070?lang=zh_cn&edition=full","pubTime":"2025-05-17 00:00","pubTimestamp":1747411218,"startTime":"0","endTime":"0","summary":"5月17日，Mirum Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第一财季净利润为-14.68百万美元，同比增加41.93%；其中营业收入为1.12亿美元，同比增加61.80%，每股基本收益为-0.30美元。从资产负债表来看，Mirum Pharmaceuticals, Inc.总负债4.57亿美元，其中短期债务1.64百万美元，资产负债比为1.51，流动比率为3.22。机构评级：截至2025年5月17日，当前有10家机构对Mirum Pharmaceuticals, Inc.目标价做出预测，其中目标均价为68.50美元，其中最低目标价为53.00美元，最高目标价为79.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000031a6e1d8b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517000031a6e1d8b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM"],"gpt_icon":0},{"id":"2535836200","title":"雷蒙德詹姆斯公司：维持Mirum Pharmaceuticals评级，由强烈买入调整至强烈买入评级, 目标价由73.00美元调整至77.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2535836200","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535836200?lang=zh_cn&edition=full","pubTime":"2025-05-14 02:20","pubTimestamp":1747160428,"startTime":"0","endTime":"0","summary":"雷蒙德詹姆斯公司：维持Mirum Pharmaceuticals(MIRM.US)评级，由强烈买入调整至强烈买入评级, 目标价由73.00美元调整至77.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051402231997589463&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051402231997589463&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM"],"gpt_icon":0},{"id":"2534346824","title":"摩根大通证券公司：维持Mirum Pharmaceuticals(MIRM.US)评级，由优于大市调整至优于大市评级, 目标价由74.00美元调整至76.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534346824","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534346824?lang=zh_cn&edition=full","pubTime":"2025-05-09 23:25","pubTimestamp":1746804309,"startTime":"0","endTime":"0","summary":"摩根大通证券公司：维持Mirum Pharmaceuticals(MIRM.US)评级，由优于大市调整至优于大市评级, 目标价由74.00美元调整至76.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09232550280596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MIRM","159848","399975"],"gpt_icon":0},{"id":"1154977947","title":"异动解读 | 罕见疾病治疗领军企业Mirum Pharmaceuticals盘中大涨8.78%，获券商一致看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1154977947","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154977947?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:36","pubTimestamp":1746714987,"startTime":"0","endTime":"0","summary":"专注于罕见疾病和孤儿病治疗的生物制药公司Mirum Pharmaceuticals, Inc.今日盘中股价大涨8.78%，引发市场广泛关注。该公司主要产品Livmarli是一种新型口服IBAT抑制剂，用于治疗Alagille综合征患者的胆汁淤积性瘙痒症。尽管Mirum Pharmaceuticals最近的财报显示净亏损8794万美元，每股亏损1.85美元，但公司营业收入达到3.37亿美元，毛利2.55亿美元，显示出强劲的销售增长潜力。与此同时，生物技术行业整体呈现下跌趋势，跌幅为3.34%。在这一背景下，Mirum Pharmaceuticals的强劲表现更显突出。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 罕见疾病治疗领军企业Mirum Pharmaceuticals盘中大涨8.78%，获券商一致看好","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MIRM"],"gpt_icon":0},{"id":"2533139234","title":"Mirum Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533139234","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533139234?lang=zh_cn&edition=full","pubTime":"2025-05-08 21:40","pubTimestamp":1746711653,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日21时40分，Mirum Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.51%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.34%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司， 专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。它参与了 Maralixibat 的开发，用于治疗患有进行性家族性肝内胆汁淤积症或 PFIC 和 Alagille 综合征或 ALGS 的儿科患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508214100a476d185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508214100a476d185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2533652229","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大跌5.14%报41.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533652229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533652229?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:38","pubTimestamp":1746549504,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时38分，Mirum Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.14%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为5.00%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司， 专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507003825a6d541ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507003825a6d541ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2516480605","title":"Mirum Pharmaceuticals, Inc.2024财年实现净利润-87.94百万美元，同比增加46.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516480605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516480605?lang=zh_cn&edition=full","pubTime":"2025-03-03 00:01","pubTimestamp":1740931269,"startTime":"0","endTime":"0","summary":"3月3日，Mirum Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-87.94百万美元，同比增加46.05%；其中营业收入为3.37亿美元，同比增加81.18%，每股基本收益为-1.85美元。从资产负债表来看，Mirum Pharmaceuticals, Inc.总负债4.45亿美元，其中短期债务1.71百万美元，资产负债比为1.51，流动比率为3.10。机构评级：截至2025年3月3日，当前有9家机构对Mirum Pharmaceuticals, Inc.目标价做出预测，其中目标均价为66.11美元，其中最低目标价为55.00美元，最高目标价为74.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000148abe4acd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303000148abe4acd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM"],"gpt_icon":0},{"id":"2514651385","title":"Mirum Pharmaceuticals, Inc.盘中异动 早盘大幅跳水7.68%报46.64美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514651385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514651385?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666722,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Mirum Pharmaceuticals, Inc.股票出现波动，股价急速下跌7.68%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272232029632b0e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272232029632b0e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"1103386476","title":"Mirum Pharmaceuticals 2024年第四季度GAAP每股收益$(0.49)不及预期$(0.28)，销售额为9943万美元，超出预期9660.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1103386476","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103386476?lang=zh_cn&edition=full","pubTime":"2025-02-27 06:10","pubTimestamp":1740607806,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals 报告季度每股亏损$，比分析师的预期$低75%。公司报告季度销售额为9943万美元，超出分析师预期的9660.6万美元，超出2.92%。这较去年同期的销售额6955.4万美元增长了42.95%。以上内容来自Benzinga Earnings专栏，原文如下：Mirum Pharmaceuticals  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 75 percent. This is a 25.76 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $99.430 million which beat the analyst consensus estimate of $96.606 million by 2.92 perce","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM"],"gpt_icon":0},{"id":"1113916189","title":"Mirum Pharmaceuticals第四季度销售额为9943万美元，超出预期的9660.6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1113916189","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113916189?lang=zh_cn&edition=full","pubTime":"2025-02-27 05:18","pubTimestamp":1740604735,"startTime":"0","endTime":"0","summary":"Mirum Pharmaceuticals报告季度销售额为9943万美元，超出分析师一致预期的9660.6万美元，超出幅度为2.92%。这一数字较去年同期的销售额6955.4万美元增长了42.95%。以上内容来自Benzinga Earnings专栏，原文如下：Mirum Pharmaceuticals  reported quarterly sales of $99.430 million which beat the analyst consensus estimate of $96.606 million by 2.92 percent.  This is a 42.95 percent increase over sales of $69.554 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Mirum Pharmaceuticals第四季度销售额为9943万美元，超出预期的9660.6万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MIRM"],"gpt_icon":0},{"id":"2512195529","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大涨5.26%报52.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512195529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512195529?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:47","pubTimestamp":1739900859,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时47分，Mirum Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.26%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Aditxt, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Solid Biosciences Inc.涨幅较大，Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃，换手率分别为578.27%、191.01%、160.48%，振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.，振幅分别为148.75%、92.00%、79.17%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190147409627b77d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190147409627b77d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2509235899","title":"Mirum Pharmaceuticals, Inc.盘中异动 快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509235899?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:04","pubTimestamp":1738771463,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时04分，Mirum Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.04%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，Transcode Therapeutics, Inc.、Oragenics Inc.、Pasithea Therapeutics Corp.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4210.56%、1602.51%、1281.89%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028，振幅分别为99.51%、59.80%、54.05%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206000423a23a9150&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206000423a23a9150&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2505970043","title":"Mirum Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505970043","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505970043?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:23","pubTimestamp":1737649389,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时23分，Mirum Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.05%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Exicure, Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Dogwood Therapeutics, Inc.、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为3561.05%、1912.44%、653.19%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Jupiter Neurosciences, Inc.，振幅分别为186.07%、64.29%、55.57%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124002309abb61238&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124002309abb61238&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2503362472","title":"Mirum Pharmaceuticals, Inc.盘中异动 急速拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503362472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503362472?lang=zh_cn&edition=full","pubTime":"2025-01-16 00:24","pubTimestamp":1736958252,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日00时24分，Mirum Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.26%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.02%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116002412abac0ce8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116002412abac0ce8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2503531119","title":"Mirum Pharmaceuticals, Inc.盘中异动 股价大涨5.05%报43.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503531119","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503531119?lang=zh_cn&edition=full","pubTime":"2025-01-14 02:30","pubTimestamp":1736793011,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日02时30分，Mirum Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.05%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Phio Pharmaceuticals Corp.、Kairos Pharma, Ltd.、Salarius Pharmaceuticals, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为13869.39%、7492.05%、711.32%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、221.73%、201.86%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114023011960277ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114023011960277ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0},{"id":"2492515633","title":"Mirum Pharmaceuticals, Inc.盘中异动 下午盘急速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492515633","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492515633?lang=zh_cn&edition=full","pubTime":"2024-12-19 04:28","pubTimestamp":1734553739,"startTime":"0","endTime":"0","summary":"北京时间2024年12月19日04时28分，Mirum Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.03%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.38%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。它参与了 Maralixibat 的开发，用于治疗患有进行性家族性肝内胆汁淤积症或 PFIC 和 Alagille 综合征或 ALGS 的儿科患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042859a1f954ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219042859a1f954ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MIRM"],"gpt_icon":0},{"id":"2490776405","title":"Mirum Pharmaceuticals, Inc.盘中异动 快速下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490776405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490776405?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:04","pubTimestamp":1733756678,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日23时04分，Mirum Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.06%。Mirum Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Mirum Pharmaceuticals, Inc.公司简介：Mirum Pharmaceuticals Inc 是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见疾病和孤儿疾病的新疗法。它参与了 Maralixibat 的开发，用于治疗患有进行性家族性肝内胆汁淤积症或 PFIC 和 Alagille 综合征或 ALGS 的儿科患者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120923043895e869f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120923043895e869f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIRM","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mirumpharma.com","stockEarnings":[{"period":"1week","weight":0.0389},{"period":"1month","weight":0.0839},{"period":"3month","weight":0.2122},{"period":"6month","weight":0.1969},{"period":"1year","weight":0.3999},{"period":"ytd","weight":0.2157}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0354},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.1172},{"period":"ytd","weight":0.0585}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mirum Pharmaceuticals, Inc.于2018年5月2日在特拉华州注册成立。该公司是一家生物制药公司，专注于识别、收购、开发和商业化用于使人衰弱的罕见和孤儿疾病的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.026003},{"month":2,"riseRate":0.833333,"avgChangeRate":0.061659},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.05038},{"month":4,"riseRate":0.5,"avgChangeRate":0.059141},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.035958},{"month":6,"riseRate":0.666667,"avgChangeRate":0.097654},{"month":7,"riseRate":0.5,"avgChangeRate":0.071631},{"month":8,"riseRate":0.666667,"avgChangeRate":0.053993},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.049627},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.124045},{"month":11,"riseRate":0.666667,"avgChangeRate":0.097857},{"month":12,"riseRate":0.5,"avgChangeRate":0.354494}],"exchange":"NASDAQ","name":"Mirum Pharmaceuticals, Inc.","nameEN":"Mirum Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mirum Pharmaceuticals, Inc.(MIRM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mirum Pharmaceuticals, Inc.(MIRM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mirum Pharmaceuticals, Inc.,MIRM,Mirum Pharmaceuticals, Inc.股票,Mirum Pharmaceuticals, Inc.股票老虎,Mirum Pharmaceuticals, Inc.股票老虎国际,Mirum Pharmaceuticals, Inc.行情,Mirum Pharmaceuticals, Inc.股票行情,Mirum Pharmaceuticals, Inc.股价,Mirum Pharmaceuticals, Inc.股市,Mirum Pharmaceuticals, Inc.股票价格,Mirum Pharmaceuticals, Inc.股票交易,Mirum Pharmaceuticals, Inc.股票购买,Mirum Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mirum Pharmaceuticals, Inc.(MIRM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mirum Pharmaceuticals, Inc.(MIRM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}